Empirico

Empirico is a venture-backed, next-generation therapeutics company founded on leveraging large-scale biological datasets, human genetics, and programmable biology to drive the discovery and development of novel targets. Empirico's Precision Insights platform is purpose-built for therapeutic discovery and utilizes world-leading datasets and advanced algorithmic approaches to identify and prioritize therapeutic targets with high translational success rates. High-priority therapeutic targets are experimentally validated in-house before advancing into preclinical development using the most optimal therapeutic modality.